首页|OpNAC1 transcription factor regulates the biosynthesis of the anticancer drug camptothecin by targeting loganic acid O-methyltransferase in Ophiorrhiza pumila

OpNAC1 transcription factor regulates the biosynthesis of the anticancer drug camptothecin by targeting loganic acid O-methyltransferase in Ophiorrhiza pumila

扫码查看
Camptothecin (CPT) is an anticancer pentacyclic quinoline alkaloid widely used to treat cancer pa-tients worldwide. However, the biosynthetic pathway and transcriptional regulation of camptothecin are largely unknown. Ophiorrhiza pumila, the herbaceous plant from the Rubiaceae family, has emerged as a model plant for studying camptothecin biosynthesis and regulation. In this study, a high-quality reference genome of O. pumila with estimated size of~456.90 Mb was reported, and the accumulation level of camptothecin in roots was higher than that in stems and leaves. Based on its spatial distribution in the plant, we examined gene functions and expression by combining genomics with transcriptomic analysis. Two loganic acid O-methyltransferase (OpLAMTs) were identified in strictosidine-producing plant O. pumila, and enzyme catalysis assays showed that OpLAMT1 and not OpLAMT2 could convert loganic acid into loganin. Further knock-out of OpLAMT1 expression led to the elimination of loganin and camptothecin accumulation in O. pumila hairy roots. Four key residues were identified in OpLAMT1 pro-tein crucial for the catalytic activity of loganic acid to loganin. By co-expression network, we identified a NAC transcription factor, OpNAC1, as a candidate gene for regulating camptothecin biosynthesis. Transgenic hairy roots and biochemical assays demonstrated that OpNAC1 suppressed OpLAMT1 expression. Here, we reported on two camptothecin metabolic engineering strategies paving the road for industrial-scale production of camptothecin in CPT-producing plants.

camptothecin biosynthesismetabolic engineering strategiesOphiorrhiza pumilaplant secondary metabolismtranscriptional regulation

Xiaolong Hao、Can Wang、Wei Zhou、Qingyan Ruan、Chenhong Xie、Yinkai Yang、Chengyu Xiao、Yan Cai、Jingyi Wang、Yao Wang、Xuebin Zhang、Itay Maoz、Guoyin Kai

展开 >

Laboratory of Medicinal Plant Biotechnology,School of Pharmaceutical Sciences,Academy of Chinese Medical Science,Zhejiang Chinese Medical University,Hangzhou 310053,China

State Key Laboratory of Crop Stress Adaptation and Improvement,Henan Joint International Laboratory for Crop Multi-Omics Research,School of Life Sciences,Henan University,Kaifeng 475001,China

Department of Postharvest Science,ARO,The Volcani Center,HaMaccabim Rd 68,POB 15159,Rishon LeZion 7528809,Israel

Major Science and Technology Projects of Breeding New Varieties of Agriculture in Zhejiang ProvinceNational Natural Science Foundation of ChinaNational Natural Science Foundation of ChinaNational Natural Science Foundation of ChinaNational Natural Science Foundation of ChinaNational Key Research and Development Program of ChinaZhejiang Provincial Natural Science Foundation of ChinaZhejiang Provincial Natural Science Foundation of ChinaZhejiang Provincial Ten Thousands Program for Leading Talents of Science and Technology InnovationZhejiang Provincial Program for the Cultivation of Highlevel Innovative Health Talents,Research Project of Zhejiang Chinese MediOpening Project of Zhejiang Provincial Key Laboratory of Resources Protection and Innovation of Traditional Chinese Medicine

2021C02074820038893157173582073963815220492018YFC1706203LQ21H280004LY20H2800082018R520502021JKZDZC062021E10013

2023

植物学报(英文版)
中国植物学会

植物学报(英文版)

CSTPCDCSCD北大核心
影响因子:0.921
ISSN:1672-9072
年,卷(期):2023.65(1)
  • 74